These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7563669)

  • 1. [An analysis of the B-cell epitopes recognized in hypervariable region 1 of hepatitis C virus in chronic persistent hepatitis].
    Nakamoto Y; Murakami S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):117-22. PubMed ID: 7563669
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis.
    Nakamoto Y; Kaneko S; Ohno H; Honda M; Unoura M; Murakami S; Kobayashi K
    J Med Virol; 1996 Sep; 50(1):35-41. PubMed ID: 8890039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral escape from humoral immune system by mutations in hypervariable region of HCV envelope protein and mechanism of persistent viral infection].
    Kato N; Nakazawa T; Sekiya H; Mizutani T; Shimotohno K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):129-35. PubMed ID: 7563673
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
    Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies.
    Akatsuka T; Donets M; Scaglione L; Ching WM; Shih JW; Di Bisceglie AM; Feinstone SM
    Hepatology; 1993 Sep; 18(3):503-10. PubMed ID: 7689529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.
    Taniguchi S; Okamoto H; Sakamoto M; Kojima M; Tsuda F; Tanaka T; Munekata E; Muchmore EE; Peterson DA; Mishiro S
    Virology; 1993 Jul; 195(1):297-301. PubMed ID: 7686313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.
    Koziel MJ; Dudley D; Wong JT; Dienstag J; Houghton M; Ralston R; Walker BD
    J Immunol; 1992 Nov; 149(10):3339-44. PubMed ID: 1385523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
    Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
    Kita H; Moriyama T; Kaneko T; Harase I; Nomura M; Miura H; Nakamura I; Yazaki Y; Imawari M
    Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
    Cerino A; Mondelli MU
    J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    Erickson AL; Houghton M; Choo QL; Weiner AJ; Ralston R; Muchmore E; Walker CM
    J Immunol; 1993 Oct; 151(8):4189-99. PubMed ID: 7691940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Forecasting of hepatitis C virus CTL epitopes and design of multi-epitopes vaccine].
    Li D; Xie YW; Xue XP; Bai XF; Jia ZS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):786-7. PubMed ID: 19874698
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles.
    Korenaga M; Hino K; Okazaki M; Okuda M; Okita K
    Biochem Biophys Res Commun; 1997 Nov; 240(3):677-82. PubMed ID: 9398625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Hepatology; 1993 Dec; 18(6):1293-9. PubMed ID: 8244252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
    Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
    Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.